CRH PLC

CRH remains in a Stage 4 decline with a clear Lower Highs & Lower Lows downtrend and bearish EMA alignment. Price is near its 52-week low and below major EMAs, with momentum indicators not signaling a reversal. Short-term timing is neutral, suggesting deferment of sell execution. Preferred approach is to trim into the nearby EMA and resistance cluster rather than initiate fresh sell positions.

• ↑Q2 revenue grew 6% YoY to $10.8 billion; adjusted EBITDA rose 7% to $2.6 billion.
• ↑Arcosa deal at $150/share targets ~$175 million synergies within three years.
• ↓Elevated haulage and raw‐material inflation squeeze margins despite efficiency gains.